Search for: "BARR v. USA" Results 41 - 60 of 94
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
5 Jun 2007, 1:52 pm
Burr and Geico v. [read post]
8 Oct 2009, 6:05 am
Teva Pharmaceuticals USA, Inc (Patent Docs) (Patent Baristas) (GenericsWeb)   General Biotech legislative agenda: healthcare, energy, patents and capital (IP Watch) India: Applying for patents does pay: Wockhardt wins kudos from the Indian government (SPICY IP) US: CAFC ruling in Board of Trustees of the Leland Stanford Junior University et al v Roche Molecular Systems et al - How to lose a patent? [read post]
24 Nov 2010, 12:37 am by Kelly
General Global pharmaceutical linkage regulations: A consortium framework (IP Osgoode) Pfizer rolling out generics to grab off-patent market (GenericsWeb) Australia: Too little too late: CSL Limited v Novo Nordisk Pharmaceuticals Pty Ltd (No 2) and the judicial discretion to amend a patent (IP Whiteboard) Brazil: You lost your chance! [read post]
23 Jul 2020, 2:40 pm by Matt Gluck
Nathaniel Sobel discussed the recent developments in the Trump v. [read post]
14 Apr 2020, 3:43 am by Florian Mueller
.] ; and that Apple 'attempts to exaggerate Uniloc's ties to California'" (emphasis added)Source: Memorandum Order and Opinion at 16-17, Uniloc USA, Inc. v. [read post]
28 Apr 2011, 9:55 pm by Sylvain Métille
Depuis peu il est possible de partager des bons plans avec Deals, un projet similaire à Groupon aux USA ou DeinDeal en Suisse. [read post]
19 Jun 2011, 10:13 pm
Saab Cars USA, Inc. v. [read post]
29 Jun 2010, 6:01 pm by Duncan
USA (Patent Docs) Lexapro (Escitalopram) – US: Infosint’s infringement verdict over Lexapro overturned, patent ruled invalid (Patent Docs) Niaspan (Niacin) – US: Patent infringement complaint filed following a Paragraph IV certification: Abbott Laboratories et al. v. [read post]
30 Jun 2010, 5:52 am
USA (Patent Docs) Lexapro (Escitalopram) – US: Infosint’s infringement verdict over Lexapro overturned, patent ruled invalid (Patent Docs) Niaspan (Niacin) – US: Patent infringement complaint filed following a Paragraph IV certification: Abbott Laboratories et al. v. [read post]
17 Jan 2008, 10:00 pm
: (Against Monopoly),Structuring a decentralized world - Institute for Ethics and Emerging Technologies: The necessity of open biotechnology: (Patent Lens),A skeptical look at the Automated Content Access Protocol: (Ars Technica),5 practical things to incorporate in a corporate IP strategy: (IP ThinkTank), Legal models for online content enforcement: (OpenContentLawyer),Germany, Chinese copies and misdirected ‘strategy': (IP… [read post]
23 Jun 2009, 9:46 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Eloxatin (Oxaliplatin) – US: District Court New Jersey grants summary judgment of non-infringement in favour of Hospira, Teva and others concerning patent relating to Sanofi’s Eloxatin: Sanofi-Aventis v Sandoz (SmartBrief) (The IP Factor) (GenericsWeb) (Patents4Life) General Europe’s ever changing landscape… [read post]
10 Jul 2020, 4:11 am by James Romoser
At Mayer Brown’s Class Defense Blog, Archis Parasharami, Kevin Ranlett and Daniel Jones analyze the court’s recent decision in Barr v. [read post]